Glipizide, a medication used to lower blood sugar in type 2 diabetes, most commonly causes digestive issues, dizziness, and low blood sugar. In clinical trials, about 5 to 7 percent of people taking glipizide experienced at least one notable side effect beyond hypoglycemia. Most of these are mild and manageable, but some deserve closer attention.
The Most Common Side Effects
In placebo-controlled clinical trials of the extended-release form, the side effects reported most often were dizziness (6.8% of patients), diarrhea (5.4%), nervousness (3.6%), tremor (3.6%), and gas (3.2%). Diarrhea and tremor stood out because they didn’t occur at all in the placebo group, suggesting they’re genuinely caused by the medication rather than by chance.
Other gastrointestinal symptoms like nausea, vomiting, constipation, and indigestion occurred in fewer than 3% of people in trials but were still more common than with a placebo. These digestive side effects are often less bothersome when the medication is taken with food. The immediate-release tablet should be taken at least 30 minutes before breakfast, while the extended-release version is designed to be taken with breakfast, which can help reduce stomach upset.
Low Blood Sugar Is the Biggest Concern
Glipizide works by stimulating the pancreas to release more insulin, which means it can push blood sugar too low. This is the most clinically important side effect. In trials of the extended-release form, 3.4% of patients had a confirmed low blood sugar episode, defined as a blood glucose reading below 60 mg/dL or symptoms consistent with hypoglycemia. In a head-to-head comparison of extended-release and immediate-release glipizide, the rate dropped to less than 1% for both.
Symptoms of low blood sugar include shakiness, sweating, confusion, a fast heartbeat, irritability, and feeling suddenly very hungry. In more severe cases, you might feel weak, have blurred vision, or have trouble concentrating. These episodes are more likely if you skip a meal, exercise more than usual, or drink alcohol while taking glipizide.
Certain people face a higher risk. If you have kidney or liver problems, your body may clear glipizide more slowly, leading to higher drug levels in your blood and a greater chance of a dangerous drop in blood sugar. Reduced liver function also limits the body’s ability to produce its own glucose as a safety net, compounding the risk. For these reasons, people with kidney or liver disease often need lower doses and more gradual dose adjustments.
How Alcohol Changes the Picture
Drinking alcohol while on glipizide raises your risk of low blood sugar on its own, since alcohol interferes with the liver’s ability to release stored glucose. But there’s a second, less common interaction: glipizide can occasionally trigger a disulfiram-like reaction when combined with alcohol. This causes facial flushing, nausea, vomiting, dizziness, and stomach pain. The reaction is rare but unpleasant enough that limiting alcohol intake is a practical precaution.
Rare but Serious Reactions
A small number of people have experienced more severe effects during glipizide use, though these are very uncommon. Reported reactions include cholestatic jaundice, a condition where bile flow from the liver is blocked, leading to yellowing of the skin and eyes, dark urine, and itching. This is thought to be a hypersensitivity (allergic-type) reaction rather than direct liver toxicity.
Blood cell abnormalities have also been reported in rare cases, including very low white blood cell counts and low platelet counts. Temporary changes in liver function tests have occurred as well. It’s worth noting that a clear causal link between these events and glipizide hasn’t been firmly established, but they are listed in prescribing information as potential concerns.
Cardiovascular Safety Questions
Glipizide belongs to a class of drugs called sulfonylureas, which have carried a cloud of cardiovascular concern since the 1970s. An early study of a related drug, tolbutamide, suggested increased cardiovascular deaths compared to diet treatment alone. The FDA added a warning to all sulfonylurea labels based on that finding.
The evidence since then has been mixed. More recent and larger studies haven’t consistently confirmed an elevated heart risk with modern sulfonylureas like glipizide, but the warning remains on the label. This is one reason many doctors now prefer newer diabetes medications that have been shown to have neutral or even protective cardiovascular effects. If you’re already taking glipizide and your blood sugar is well controlled without frequent lows, this historical concern alone isn’t necessarily a reason to switch, but it’s a reasonable topic to raise with your prescriber.
What Side Effects Feel Like Day to Day
For most people, the experience of taking glipizide is uneventful. The side effects that do come up tend to cluster in the first weeks of treatment or after a dose increase. Dizziness and tremor, for example, often overlap with mild drops in blood sugar that your body adjusts to over time. Digestive symptoms like diarrhea and gas also tend to improve as your system gets used to the medication.
The side effect that requires ongoing vigilance is hypoglycemia. Unlike a temporary bout of nausea, low blood sugar can happen unpredictably months or years into treatment, especially if your eating patterns, activity level, or kidney function change. Keeping a fast-acting source of glucose on hand (juice, glucose tablets, regular soda) is a practical habit for anyone on this medication. Recognizing the early signs of a low, like sudden sweating or hunger, lets you correct it before it becomes serious.